4-(4-(Dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-one

Catalog No. :
ACQBDS413
CAS No. :
1564-29-0
Molecular Formula :
C18H16N2O2
Molecular Weight :
292.34

IUPAC Name:(E)-4-(4-(dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-one

4-(4-(Dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-(Dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-one
IUPAC Name(E)-4-(4-(dimethylamino)benzylidene)-2-phenyloxazol-5(4H)-one
Molecular FormulaC18H16N2O2
Molecular Weight292.34
SMILESCN(C)C1=CC=C(/C=C2/N=C(C3=CC=CC=C3)OC2=O)C=C1
InChI KeyGVIKVHOLUBDIRH-FOWTUZBSSA-N
Synonym2-Phenyl-4-[p-(dimethylamino)benzylidene]-2-oxazoline-5-one;4-[4-(Dimethylamino)benzylidene]-2-phenyloxazole-5(4H)-one;4-[p-(Dimethylamino)benzylidene]-2-phenyl-2-oxazolin-5-one;Orange Red II;4-[4-(Dimethylamino)benzylidene]-2-phenyl-2-oxazolin-5-one (Luminore orange-red 612 T);(4E)-4-[[4-(dimethylamino)phenyl]methylidene]-2-phenyl-1,3-oxazol-5-one;4-[4-(Dimethylamino)benzylidene]-2-phenyl-2-oxazolin-5-one;4-(4-Dimethylaminobenzyliden)-2-phenyloxazolone-5 (Luminore orange-red 612 T )
CAS No.1564-29-0

Synthetic Route by SureRoute

1. ACQBDS413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBNPV839 route compound structure diagram
    ACBNPV839100-10-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQBDS413 route product structure diagram
    ACQBDS4131564-29-0
Inquiry

2. ACQBDS413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLBEQ951 route compound structure diagram
    ACLBEQ951586-77-6 In Stock
  4. Then
  5. ACQBDS413 route product structure diagram
    ACQBDS4131564-29-0
Inquiry

Comments (0)